Testing effectiveness (Phase 2)Study completedNCT02170077What this trial is testingA Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093Who this might be right forEpilepsy Bial - Portela C S.A. 144
Post-approval studies (Phase 4)Ended earlyNCT01546688What this trial is testingEvaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial SeizuresWho this might be right forEpilepsy Eisai Limited 41
Large-scale testing (Phase 3)Study completedNCT00425282What this trial is testingThe Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.Who this might be right forEpilepsyEpilepsy, FocalSeizure Disorder+2 more SK Life Science, Inc. 566
Large-scale testing (Phase 3)Study completedNCT01618695What this trial is testingA Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset SeizuresWho this might be right forPartial-onset Seizures Eisai Co., Ltd. 940
Large-scale testing (Phase 3)Study completedNCT01262677What this trial is testingOnce-A-Day Pregabalin For Partial SeizuresWho this might be right forPartial SeizuresEpilepsies, Partial Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Testing effectiveness (Phase 2)Study completedNCT00236860What this trial is testingThe Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresWho this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Post-approval studies (Phase 4)Ended earlyNCT05605756What this trial is testingBOTOX Effects on Seizure Severity and SusceptibilityWho this might be right forDrug-resistant Focal Seizure Beth Israel Deaconess Medical Center 3
Testing effectiveness (Phase 2)Ended earlyNCT02625090What this trial is testingAn Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyWho this might be right forHighly Drug-resistant Focal Epilepsy UCB Biopharma SRL 42
Not applicableStudy completedNCT04770337What this trial is testingPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal EpilepsyWho this might be right forRefractory EpilepsyFocal SeizureSeizures, Focal+4 more Neuroelectrics Corporation 127
Testing effectiveness (Phase 2)Looking for participantsNCT05518578What this trial is testingSafety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant EpilepsyWho this might be right forEpilepsySeizures, Epileptic Supernus Pharmaceuticals, Inc. 60
Large-scale testing (Phase 3)Study completedNCT01228747What this trial is testingA Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)Who this might be right forEpilepsyGeneralized Tonic-Clonic Seizures UCB Japan Co. Ltd. 361
Large-scale testing (Phase 3)Study completedNCT00141336What this trial is testingTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.Who this might be right forSeizure Disorder, Partial Pfizer 750
Large-scale testing (Phase 3)Ended earlyNCT00310388What this trial is testingOpen-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097Who this might be right forEpilepsy GlaxoSmithKline 376
Testing effectiveness (Phase 2)Study completedNCT03373383What this trial is testingStudy to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyWho this might be right forDrug-resistant EpilepsyFocal-Onset Seizures UCB Biopharma S.P.R.L. 411
Not applicableStudy completedNCT05747001What this trial is testingThis is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UKWho this might be right forFocal Onset SeizureEpilepsy Aziende Chimiche Riunite Angelini Francesco S.p.A 319
Post-approval studies (Phase 4)Study completedNCT01630057What this trial is testingEvaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic DrugWho this might be right forPartial Seizures Eisai Inc. 200
Large-scale testing (Phase 3)Study completedNCT00740623What this trial is testingThe Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.Who this might be right forEpilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more SK Life Science, Inc. 547
Not applicableStudy completedNCT00684424What this trial is testingNon-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure FrequencyWho this might be right forEpilepsy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 199
Large-scale testing (Phase 3)Study completedNCT01392768What this trial is testingEfficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationWho this might be right forEpilepsyPartial Seizures Ache Laboratorios Farmaceuticos S.A. 126
Large-scale testing (Phase 3)Study completedNCT00220415What this trial is testingA Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary GeneralizationWho this might be right forPartial Seizures With or Without Secondary Generalization UCB Pharma